Total planned funding: $300,972,394
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $61,925,255 |
| Mozambique | $53,719,495 |
| Zambia | $40,092,298 |
| South Africa | $19,194,797 |
| Vietnam | $13,699,633 |
| Tanzania | $13,074,411 |
| Rwanda | $11,149,961 |
| Haiti | $10,286,452 |
| India | $9,792,311 |
| Kenya | $9,604,236 |
| Cambodia | $7,275,000 |
| Côte d'Ivoire | $5,847,736 |
| Indonesia | $4,976,794 |
| Burundi | $4,608,504 |
| Zimbabwe | $4,344,201 |
| Uganda | $3,805,686 |
| Asia Regional Program | $3,400,093 |
| Democratic Republic of the Congo | $3,390,975 |
| Ethiopia | $3,121,914 |
| Botswana | $2,840,003 |
| Malawi | $2,701,446 |
| Caribbean Region | $2,525,420 |
| Papua New Guinea | $2,486,306 |
| Angola | $2,466,719 |
| Eswatini | $2,047,187 |
| China | $1,500,000 |
| South Sudan | $566,962 |
| Thailand | $278,599 |
| Dominican Republic | $250,000 |
| Central Asia Region | $0 |
Organizational Types
| NGO | $293,302,394 |
| Implementing Agency | $7,670,000 |
Program Areas
| Treatment | $84,287,395 |
| Prevention | $82,662,332 |
| Care | $77,310,139 |
| Governance and Systems | $29,169,470 |
| Testing | $27,543,058 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $72,610,468 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $45,032,179 |
| HKID: Care: Orphans and Vulnerable Children | $34,276,104 |
| HBHC: Care: Adult Care and Support | $28,883,477 |
| HVCT: Testing: HIV Testing and Counseling | $27,543,058 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,645,008 |
| HLAB: Laboratory Infrastructure | $11,689,304 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,385,616 |
| HVSI: Strategic Information | $10,010,932 |
| PDTX: Treatment: Pediatric Treatment | $8,253,643 |
| OHSS: Health Systems Strengthening | $7,469,234 |
| HVTB: Care: TB/HIV | $7,282,547 |
| PDCS: Care: Pediatric Care and Support | $6,868,011 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,308,947 |
| HTXD: Treatment: ARV Drugs | $3,423,284 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $1,542,969 |
| HMBL: Biomedical Prevention: Blood Safety | $394,929 |
| HMIN: Biomedical Prevention: Injection Safety | $352,684 |